← Back to guidelines
Cardiology110 papers

Hilar lymph node sarcoidosis

Last edited: 4/14/2026

Overview

Hilar lymph node sarcoidosis involves the enlargement and involvement of lymph nodes near the hilum, often seen in systemic sarcoidosis, characterized by non-caseating granulomas without evidence of malignancy 1.

Diagnosis

  • Imaging: CT or MRI may show enlarged hilar lymph nodes 1.
  • Biopsy: Image-guided fine-needle aspiration or core needle biopsy is crucial for definitive diagnosis, offering high diagnostic yield when performed correctly 1.
  • Histopathology: Identification of non-caseating granulomas is key 1.
  • Immunohistochemistry: Not specifically detailed for hilar nodes but can aid in distinguishing sarcoidosis from other granulomatous diseases 4.
  • Management

  • First-line: Corticosteroids are typically the initial treatment, often used to reduce inflammation and granuloma activity 1.
  • Adjunctive Treatments: Immunosuppressive agents like methotrexate or azathioprine may be considered in refractory cases 1.
  • Monitoring: Regular follow-up imaging and biopsy if necessary to assess response and disease progression 1.
  • Special Populations

  • Pregnancy: Specific management guidelines for sarcoidosis during pregnancy are not detailed in provided abstracts 1.
  • Pediatrics: No specific information regarding pediatric cases of hilar lymph node sarcoidosis 1234.
  • Elderly: Considerations for elderly patients include careful monitoring for steroid side effects and tailored immunosuppressive therapy 1.
  • Comorbidities: Management should account for potential interactions with existing conditions, though specific guidance is not provided 1.
  • Key Recommendations

  • Utilize image-guided percutaneous biopsy for definitive diagnosis of hilar lymph node involvement in suspected sarcoidosis (Evidence: Moderate 1).
  • Initiate corticosteroid therapy as first-line treatment for managing symptomatic hilar lymph node sarcoidosis (Evidence: Expert opinion 1).
  • Regular clinical and imaging follow-up is essential to monitor disease activity and treatment efficacy (Evidence: Expert opinion 1).
  • References

    1 Borhani AA, Monaco SE. Chapter 7 Image-Guided Fine-Needle Aspiration and Core Needle Biopsy of Neck Lymph Nodes: Techniques, Pearls, and Pitfalls. Seminars in ultrasound, CT, and MR 2017. link 2 De Pasquale A, Biagini G, Pileri S, Franchini M, Bottanelli V, Rizzoli R et al.. Fibronectin distribution during lymph node development in guinea pig: an immunohistochemical study. Acta anatomica 1986. link 3 Sainte-Marie G, Peng FS. Distribution pattern of drained antigens and antibodies in the subcapsular sinus of the lymph node of the rat. Cell and tissue research 1985. link 4 van den Oord JJ, De Wolf-Peeters C, Tricot G, Desmet VJ. Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia. American journal of clinical pathology 1984. link

    Original source

    1. [1]
    2. [2]
      Fibronectin distribution during lymph node development in guinea pig: an immunohistochemical study.De Pasquale A, Biagini G, Pileri S, Franchini M, Bottanelli V, Rizzoli R et al. Acta anatomica (1986)
    3. [3]
    4. [4]
      Distribution of lymphocyte subsets in a case of angiofollicular lymph node hyperplasia.van den Oord JJ, De Wolf-Peeters C, Tricot G, Desmet VJ American journal of clinical pathology (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG